XML 56 R42.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurements - Reconciliation of Equity Securities Measured at Fair Value on Recurring Basis (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]      
Balance at beginning of period $ 63.7    
Purchases 7.7 $ 4.6 $ 0.0
Unrealized gain (loss) included in earnings 30.8 20.9 (17.7)
Balance at ending of period 102.1 63.7  
Level 3 | Fair value measurements recurring | Equity securities–biotechnology industry      
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]      
Purchases 0.0 4.6 0.0
Level 3 | Fair value measurements recurring | Equity securities–biotechnology industry      
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]      
Balance at beginning of period 11.0 38.2 55.9
Unrealized gain (loss) included in earnings 20.8 20.9 (17.7)
Transfers out of Level 3 (31.8) (52.7) 0.0
Balance at ending of period $ 0.0 $ 11.0 $ 38.2